See more : Aareal Bank AG (AAALF) Income Statement Analysis – Financial Results
Complete financial analysis of Wesana Health Holdings Inc. (WSNAF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Wesana Health Holdings Inc., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Mindteck (India) Limited (MINDTECK.NS) Income Statement Analysis – Financial Results
- NSD Co., Ltd. (9759.T) Income Statement Analysis – Financial Results
- LABELKRAFT TECHNOLOGIES LIMITE (LABELKRAFT.BO) Income Statement Analysis – Financial Results
- Cerence Inc. (0S6.DE) Income Statement Analysis – Financial Results
- Intelicanna Ltd (INTL.TA) Income Statement Analysis – Financial Results
Wesana Health Holdings Inc. (WSNAF)
About Wesana Health Holdings Inc.
Wesana Health Holdings Inc, a life sciences company, engages in the development and delivery of psychedelic medicines and psilocybin-assisted psychotherapies to treat traumatic brain injuries. It is developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological, and mental health ailments caused by trauma. The company is based in Chicago, Illinois.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 267.21K | 30.20K | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 185.65K | 20.08K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 81.56K | 10.13K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 30.52% | 33.53% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 3.01M | 25.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 3.00M | 9.77M | 63.90K | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 65.90K | 847.09K | 8.41K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.12M | 3.06M | 10.62M | 72.31K | 102.39K | 40.19K | 66.91K | 171.69K |
| Other Expenses | 0.00 | 135.78K | -1.61M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.12M | 3.06M | 13.68M | 97.31K | 102.39K | 40.19K | 66.91K | 171.69K |
| Cost & Expenses | 1.12M | 3.06M | 13.87M | 117.38K | 102.39K | 40.19K | 66.91K | 171.69K |
| Interest Income | 24.41K | 56.67K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 7.72K | 75.17K | 30.12K | 0.00 | 0.00 | 0.00 | 0.00 | 92.96K |
| Depreciation & Amortization | 167.90K | 228.49K | 53.33K | 206.30K | 171.86K | 161.14K | 0.00 | 0.00 |
| EBITDA | -2.06M | -2.87M | -4.68M | -87.18K | -101.53K | -40.19K | -66.91K | -171.69K |
| EBITDA Ratio | 0.00% | 0.00% | -5,069.41% | -288.67% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -1.12M | -2.87M | -13.60M | -87.18K | -102.39K | -40.19K | -66.91K | -171.69K |
| Operating Income Ratio | 0.00% | 0.00% | -5,089.37% | -288.67% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -939.81K | -18.87K | 7.26M | 0.00 | 863.00 | -1.00 | -131.04K | -766.68K |
| Income Before Tax | -2.06M | -3.17M | -34.34M | -87.18K | -101.53K | -40.19K | -197.95K | -938.37K |
| Income Before Tax Ratio | 0.00% | 0.00% | -12,851.23% | -288.67% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -309.94K | 5.43M | 30.12K | -87.18K | -171.86K | -161.14K | 0.00 | 0.00 |
| Net Income | -1.75M | -8.60M | -34.34M | -87.18K | -101.53K | -40.19K | -197.95K | -938.37K |
| Net Income Ratio | 0.00% | 0.00% | -12,851.23% | -288.67% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.05 | -0.25 | -1.48 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.05 | -0.25 | -1.48 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 35.04M | 34.38M | 23.15M | 12.58M | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out (Dil) | 35.04M | 34.38M | 23.15M | 12.58M | 0.00 | 0.00 | 0.00 | 0.00 |
Wesana Health Announces Restructuring of Promissory Note Receivable
Chicago, Illinois and Toronto, Ontario--(Newsfile Corp. - November 28, 2023) - Wesana Health Holdings Inc. (CSE: WESA.X) (OTCQB: WSNAF) (the "Company"), announced the execution of a Confidential Settlement and Release Agreement ("Settlement Agreement") between Wesana Health Clinics Corp. ("Wesana"), a subsidiary of...
CSE Bulletin: Symbol Change - Inactive Designation - Wesana Health Holdings Inc. (WESA)
Toronto, Ontario--(Newsfile Corp. - Le 11 juillet/July 2023) - The Exchange has determined that Wesana Health Holdings Inc. (the “Issuer”) has not met the continued listing requirements as set out in CSE Policy 2, Appendix A, section 2A.6. Pursuant to...
Psychedelics Biotech Companies Mark New Milestones In Drug Development Pipelines: Field Trip, Cybin and Wesana
On Tuesday, three public companies in the psychedelics/biotech space announced significant milestones in their drug development pipelines. Field Trip Receives Notice Of Patent Allowance For Proprietary Psychedelic Molecule Field Trip Health (NASDAQ:FTRP) received a notice of allowance for a US...
Wesana Health CEO leveraging personal and professional experience to help patients achieve better mental health outcomes
Former Chicago Blackhawks enforcer Daniel Carcillo spent much of his NHL career getting inside the heads of opposing teams, making sure they knew that if they crossed a certain line, things could go sideways. Today, Carcillo is an entrepreneur whose...
Source: https://incomestatements.info
Category: Stock Reports